 | • レポートコード：D005-11486 • 出版社/出版日：GlobalInfoResearch / 2020年5月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、オピオイドの世界市場を広く調査・分析し、今後の市場展望をまとめております。オピオイドの種類別市場規模（即時放出/短時間作用型オピオイド、徐放/長時間作用型オピオイド）、用途別市場規模（鎮痛、麻酔、咳抑制、下痢抑制、中毒）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Purdue Pharma L.P.、Pfizer, Inc.、West-Ward Pharmaceuticals Corporation、Sun Pharmaceutical Industries Limited.、Allergan、Egalet Corporation、Janssen Pharmaceuticals, Inc. ・地域別グローバル市場分析 2015年-2020年 ・オピオイドの北米市場（アメリカ、カナダ、メキシコ） ・オピオイドのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・オピオイドのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・オピオイドの南米市場（ブラジル、アルゼンチン） ・オピオイドの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：即時放出/短時間作用型オピオイド、徐放/長時間作用型オピオイド ・用途別分析：鎮痛、麻酔、咳抑制、下痢抑制、中毒 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Opioids market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.4% in the forecast period of 2020 to 2025 and will expected to reach USD 16810 million by 2025, from USD 15260 million in 2019.
The Opioids market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Opioids market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Opioids market has been segmented into
Immediate-Release/Short-Acting Opioid
Extended-Release/Long-Acting Opioid
By Application, Opioids has been segmented into:
Pain Relief
Anesthesia
Cough Suppression
Diarrhea Suppression
Deaddiction
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Opioids market presented in the report. This section sheds light on the sales growth of different regional and country-level Opioids markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Opioids market.
The report offers in-depth assessment of the growth and other aspects of the Opioids market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Opioids Market Share Analysis
Opioids competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Opioids sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Opioids sales, revenue and market share for each player covered in this report.
The major players covered in Opioids are:
Purdue Pharma L.P.
Pfizer, Inc.
West-Ward Pharmaceuticals Corporation
Sun Pharmaceutical Industries Limited.
Allergan
Egalet Corporation
Janssen Pharmaceuticals, Inc.
Among other players domestic and global, Opioids market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Opioids product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Opioids, with price, sales, revenue and global market share of Opioids in 2018 and 2019.
Chapter 3, the Opioids competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Opioids breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Opioids market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Opioids sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Opioids Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Opioids Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Immediate-Release/Short-Acting Opioid
1.2.3 Extended-Release/Long-Acting Opioid
1.3 Market Analysis by Application
1.3.1 Overview: Global Opioids Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pain Relief
1.3.3 Anesthesia
1.3.4 Cough Suppression
1.3.5 Diarrhea Suppression
1.3.6 Deaddiction
1.4 Overview of Global Opioids Market
1.4.1 Global Opioids Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Purdue Pharma L.P.
2.1.1 Purdue Pharma L.P. Details
2.1.2 Purdue Pharma L.P. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Purdue Pharma L.P. SWOT Analysis
2.1.4 Purdue Pharma L.P. Product and Services
2.1.5 Purdue Pharma L.P. Opioids Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Pfizer, Inc.
2.2.1 Pfizer, Inc. Details
2.2.2 Pfizer, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Pfizer, Inc. SWOT Analysis
2.2.4 Pfizer, Inc. Product and Services
2.2.5 Pfizer, Inc. Opioids Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 West-Ward Pharmaceuticals Corporation
2.3.1 West-Ward Pharmaceuticals Corporation Details
2.3.2 West-Ward Pharmaceuticals Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 West-Ward Pharmaceuticals Corporation SWOT Analysis
2.3.4 West-Ward Pharmaceuticals Corporation Product and Services
2.3.5 West-Ward Pharmaceuticals Corporation Opioids Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Sun Pharmaceutical Industries Limited.
2.4.1 Sun Pharmaceutical Industries Limited. Details
2.4.2 Sun Pharmaceutical Industries Limited. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Sun Pharmaceutical Industries Limited. SWOT Analysis
2.4.4 Sun Pharmaceutical Industries Limited. Product and Services
2.4.5 Sun Pharmaceutical Industries Limited. Opioids Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Allergan
2.5.1 Allergan Details
2.5.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Allergan SWOT Analysis
2.5.4 Allergan Product and Services
2.5.5 Allergan Opioids Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Egalet Corporation
2.6.1 Egalet Corporation Details
2.6.2 Egalet Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Egalet Corporation SWOT Analysis
2.6.4 Egalet Corporation Product and Services
2.6.5 Egalet Corporation Opioids Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Janssen Pharmaceuticals, Inc.
2.7.1 Janssen Pharmaceuticals, Inc. Details
2.7.2 Janssen Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Janssen Pharmaceuticals, Inc. SWOT Analysis
2.7.4 Janssen Pharmaceuticals, Inc. Product and Services
2.7.5 Janssen Pharmaceuticals, Inc. Opioids Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Opioids Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Opioids Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Opioids Manufacturer Market Share in 2019
3.3.2 Top 6 Opioids Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Opioids Sales, Revenue and Market Share by Regions
4.1.1 Global Opioids Sales and Market Share by Regions (2015-2020)
4.1.2 Global Opioids Revenue and Market Share by Regions (2015-2020)
4.2 North America Opioids Sales and Growth Rate (2015-2020)
4.3 Europe Opioids Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Opioids Sales and Growth Rate (2015-2020)
4.5 South America Opioids Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Opioids Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Opioids Sales, Revenue and Market Share by Country
5.1.1 North America Opioids Sales and Market Share by Country (2015-2020)
5.1.2 North America Opioids Revenue and Market Share by Country (2015-2020)
5.2 United States Opioids Sales and Growth Rate (2015-2020)
5.3 Canada Opioids Sales and Growth Rate (2015-2020)
5.4 Mexico Opioids Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Opioids Sales, Revenue and Market Share by Country
6.1.1 Europe Opioids Sales and Market Share by Country (2015-2020)
6.1.2 Europe Opioids Revenue and Market Share by Country (2015-2020)
6.2 Germany Opioids Sales and Growth Rate (2015-2020)
6.3 UK Opioids Sales and Growth Rate (2015-2020)
6.4 France Opioids Sales and Growth Rate (2015-2020)
6.5 Russia Opioids Sales and Growth Rate (2015-2020)
6.6 Italy Opioids Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Opioids Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Opioids Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Opioids Revenue and Market Share by Regions (2015-2020)
7.2 China Opioids Sales and Growth Rate (2015-2020)
7.3 Japan Opioids Sales and Growth Rate (2015-2020)
7.4 Korea Opioids Sales and Growth Rate (2015-2020)
7.5 India Opioids Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Opioids Sales and Growth Rate (2015-2020)
7.7 Australia Opioids Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Opioids Sales, Revenue and Market Share by Country
8.1.1 South America Opioids Sales and Market Share by Country (2015-2020)
8.1.2 South America Opioids Revenue and Market Share by Country (2015-2020)
8.2 Brazil Opioids Sales and Growth Rate (2015-2020)
8.3 Argentina Opioids Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Opioids Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Opioids Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Opioids Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Opioids Sales and Growth Rate (2015-2020)
9.3 Turkey Opioids Sales and Growth Rate (2015-2020)
9.4 Egypt Opioids Sales and Growth Rate (2015-2020)
9.5 South Africa Opioids Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Opioids Sales and Market Share by Type (2015-2020)
10.2 Global Opioids Revenue and Market Share by Type (2015-2020)
10.3 Global Opioids Price by Type (2015-2020)
11 Global Opioids Market Segment by Application
11.1 Global Opioids Sales Market Share by Application (2015-2020)
11.2 Global Opioids Revenue Market Share by Application (2015-2020)
11.3 Global Opioids Price by Application (2015-2020)
12 Market Forecast
12.1 Global Opioids Sales, Revenue and Growth Rate (2021-2025)
12.2 Opioids Market Forecast by Regions (2021-2025)
12.2.1 North America Opioids Market Forecast (2021-2025)
12.2.2 Europe Opioids Market Forecast (2021-2025)
12.2.3 Asia-Pacific Opioids Market Forecast (2021-2025)
12.2.4 South America Opioids Market Forecast (2021-2025)
12.2.5 Middle East & Africa Opioids Market Forecast (2021-2025)
12.3 Opioids Market Forecast by Type (2021-2025)
12.3.1 Global Opioids Sales Forecast by Type (2021-2025)
12.3.2 Global Opioids Market Share Forecast by Type (2021-2025)
12.4 Opioids Market Forecast by Application (2021-2025)
12.4.1 Global Opioids Sales Forecast by Application (2021-2025)
12.4.2 Global Opioids Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Opioids Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Opioids by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Opioids Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Purdue Pharma L.P. Basic Information, Manufacturing Base and Competitors
Table 8. Purdue Pharma L.P. Opioids Major Business
Table 9. Purdue Pharma L.P. Opioids Total Revenue (USD Million) (2018-2019)
Table 10. Purdue Pharma L.P. SWOT Analysis
Table 11. Purdue Pharma L.P. Opioids Product and Services
Table 12. Purdue Pharma L.P. Opioids Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Pfizer, Inc. Basic Information, Manufacturing Base and Competitors
Table 14. Pfizer, Inc. Opioids Major Business
Table 15. Pfizer, Inc. Opioids Total Revenue (USD Million) (2018-2019)
Table 16. Pfizer, Inc. SWOT Analysis
Table 17. Pfizer, Inc. Opioids Product and Services
Table 18. Pfizer, Inc. Opioids Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. West-Ward Pharmaceuticals Corporation Basic Information, Manufacturing Base and Competitors
Table 20. West-Ward Pharmaceuticals Corporation Opioids Major Business
Table 21. West-Ward Pharmaceuticals Corporation Opioids Total Revenue (USD Million) (2018-2019)
Table 22. West-Ward Pharmaceuticals Corporation SWOT Analysis
Table 23. West-Ward Pharmaceuticals Corporation Opioids Product and Services
Table 24. West-Ward Pharmaceuticals Corporation Opioids Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Sun Pharmaceutical Industries Limited. Basic Information, Manufacturing Base and Competitors
Table 26. Sun Pharmaceutical Industries Limited. Opioids Major Business
Table 27. Sun Pharmaceutical Industries Limited. Opioids Total Revenue (USD Million) (2018-2019)
Table 28. Sun Pharmaceutical Industries Limited. SWOT Analysis
Table 29. Sun Pharmaceutical Industries Limited. Opioids Product and Services
Table 30. Sun Pharmaceutical Industries Limited. Opioids Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Allergan Basic Information, Manufacturing Base and Competitors
Table 32. Allergan Opioids Major Business
Table 33. Allergan Opioids Total Revenue (USD Million) (2018-2019)
Table 34. Allergan SWOT Analysis
Table 35. Allergan Opioids Product and Services
Table 36. Allergan Opioids Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Egalet Corporation Basic Information, Manufacturing Base and Competitors
Table 38. Egalet Corporation Opioids Major Business
Table 39. Egalet Corporation Opioids Total Revenue (USD Million) (2018-2019)
Table 40. Egalet Corporation SWOT Analysis
Table 41. Egalet Corporation Opioids Product and Services
Table 42. Egalet Corporation Opioids Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Janssen Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Janssen Pharmaceuticals, Inc. Opioids Major Business
Table 45. Janssen Pharmaceuticals, Inc. Opioids Total Revenue (USD Million) (2018-2019)
Table 46. Janssen Pharmaceuticals, Inc. SWOT Analysis
Table 47. Janssen Pharmaceuticals, Inc. Opioids Product and Services
Table 48. Janssen Pharmaceuticals, Inc. Opioids Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Global Opioids Sales by Manufacturer (2018-2019) (MT)
Table 50. Global Opioids Revenue by Manufacturer (2018-2019) (USD Million)
Table 51. Global Opioids Sales by Regions (2015-2020) (MT)
Table 52. Global Opioids Sales Market Share by Regions (2015-2020)
Table 53. Global Opioids Revenue by Regions (2015-2020) (USD Million)
Table 54. North America Opioids Sales by Countries (2015-2020) (MT)
Table 55. North America Opioids Sales Market Share by Countries (2015-2020)
Table 56. North America Opioids Revenue by Countries (2015-2020) (USD Million)
Table 57. North America Opioids Revenue Market Share by Countries (2015-2020)
Table 58. Europe Opioids Sales by Countries (2015-2020) (MT)
Table 59. Europe Opioids Sales Market Share by Countries (2015-2020)
Table 60. Europe Opioids Revenue by Countries (2015-2020) (USD Million)
Table 61. Asia-Pacific Opioids Sales by Regions (2015-2020) (MT)
Table 62. Asia-Pacific Opioids Sales Market Share by Regions (2015-2020)
Table 63. Asia-Pacific Opioids Revenue by Regions (2015-2020) (USD Million)
Table 64. South America Opioids Sales by Countries (2015-2020) (MT)
Table 65. South America Opioids Sales Market Share by Countries (2015-2020)
Table 66. South America Opioids Revenue by Countries (2015-2020) (USD Million)
Table 67. South America Opioids Revenue Market Share by Countries (2015-2020)
Table 68. Middle East & Africa Opioids Sales by Countries (2015-2020) (MT)
Table 69. Middle East & Africa Opioids Sales Market Share by Countries (2015-2020)
Table 70. Middle East & Africa Opioids Revenue by Countries (2015-2020) (USD Million)
Table 71. Middle East & Africa Opioids Revenue Market Share by Countries (2015-2020)
Table 72. Global Opioids Sales by Type (2015-2020) (MT)
Table 73. Global Opioids Sales Share by Type (2015-2020)
Table 74. Global Opioids Revenue by Type (2015-2020) (USD Million)
Table 75. Global Opioids Revenue Share by Type (2015-2020)
Table 76. Global Opioids Sales by Application (2015-2020) (MT)
Table 77. Global Opioids Sales Share by Application (2015-2020)
Table 78. Global Opioids Sales Forecast by Regions (2021-2025) (MT)
Table 79. Global Opioids Market Share Forecast by Regions (2021-2025)
Table 80. Global Opioids Sales Forecast by Type (2021-2025) (MT)
Table 81. Global Opioids Market Share Forecast by Type (2021-2025)
Table 82. Global Opioids Sales Forecast by Application (2021-2025)
Table 83. Global Opioids Market Share Forecast by Application (2021-2025)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Opioids Picture
Figure 2. Global Sales Market Share of Opioids by Type in 2019
Figure 3. Immediate-Release/Short-Acting Opioid Picture
Figure 4. Extended-Release/Long-Acting Opioid Picture
Figure 5. Opioids Sales Market Share by Application in 2018
Figure 6. Pain Relief Picture
Figure 7. Anesthesia Picture
Figure 8. Cough Suppression Picture
Figure 9. Diarrhea Suppression Picture
Figure 10. Deaddiction Picture
Figure 11. Global Opioids Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Opioids Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Opioids Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Opioids Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Opioids Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Opioids Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Opioids Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Opioids Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Opioids Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Opioids Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Opioids Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Opioids Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Opioids Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Opioids Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Opioids Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Opioids Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Opioids Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Opioids Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Opioids Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Opioids Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Opioids Sales Market Share by Manufacturer in 2019
Figure 32. Global Opioids Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Opioids Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Opioids Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Opioids Sales and Growth Rate (2015-2020) (MT)
Figure 37. Global Opioids Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Opioids Revenue Market Share by Regions (2015-2020)
Figure 39. Global Opioids Revenue Market Share by Regions in 2018
Figure 40. North America Opioids Sales and Growth Rate (2015-2020)
Figure 41. Europe Opioids Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Opioids Sales and Growth Rate (2015-2020)
Figure 43. South America Opioids Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Opioids Sales and Growth Rate (2015-2020)
Figure 45. North America Opioids Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Opioids Sales Market Share by Countries (2015-2020)
Figure 47. North America Opioids Sales Market Share by Countries in 2018
Figure 48. North America Opioids Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Opioids Revenue Market Share by Countries in 2018
Figure 50. United States Opioids Sales and Growth Rate (2015-2020) (MT)
Figure 51. Canada Opioids Sales and Growth Rate (2015-2020) (MT)
Figure 52. Mexico Opioids Sales and Growth Rate (2015-2020) (MT)
Figure 53. Europe Opioids Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Opioids Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Opioids Revenue Market Share by Countries in 2019
Figure 56. Germany Opioids Sales and Growth Rate (2015-2020) (MT)
Figure 57. UK Opioids Sales and Growth Rate (2015-2020) (MT)
Figure 58. France Opioids Sales and Growth Rate (2015-2020) (MT)
Figure 59. Russia Opioids Sales and Growth Rate (2015-2020) (MT)
Figure 60. Italy Opioids Sales and Growth Rate (2015-2020) (MT)
Figure 61. Asia-Pacific Opioids Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Opioids Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Opioids Revenue Market Share by Regions 2019
Figure 64. China Opioids Sales and Growth Rate (2015-2020) (MT)
Figure 65. Japan Opioids Sales and Growth Rate (2015-2020) (MT)
Figure 66. Korea Opioids Sales and Growth Rate (2015-2020) (MT)
Figure 67. India Opioids Sales and Growth Rate (2015-2020) (MT)
Figure 68. Southeast Asia Opioids Sales and Growth Rate (2015-2020) (MT)
Figure 69. South America Opioids Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Opioids Sales Market Share by Countries in 2019
Figure 71. South America Opioids Revenue Market Share by Countries in 2019
Figure 72. Brazil Opioids Sales and Growth Rate (2015-2020) (MT)
Figure 73. Argentina Opioids Sales and Growth Rate (2015-2020) (MT)
Figure 74. Middle East and Africa Opioids Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Opioids Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Opioids Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Opioids Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Opioids Sales and Growth Rate (2015-2020) (MT)
Figure 79. Egypt Opioids Sales and Growth Rate (2015-2020) (MT)
Figure 80. Turkey Opioids Sales and Growth Rate (2015-2020) (MT)
Figure 81. South Africa Opioids Sales and Growth Rate (2015-2020) (MT)
Figure 82. Global Opioids Sales and Growth Rate (2021-2025) (MT)
Figure 83. Global Opioids Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Opioids Market Forecast (2021-2025) (MT)
Figure 85. Europe Sales Opioids Market Forecast (2021-2025) (MT)
Figure 86. Asia-Pacific Sales Opioids Market Forecast (2021-2025) (MT)
Figure 87. South America Sales Opioids Market Forecast (2021-2025) (MT)
Figure 88. Middle East & Africa Sales Opioids Market Forecast (2021-2025) (MT)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
オピオイド作動薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Opioids Agonist Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.3% in the forecast period of 2020 to 2025 and will expected to reach USD 18590 million by 2025, from USD 16980 million in 2019. The Opioids Agonist …- 合成オピオイドの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Synthetic Opioids market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Synthetic Opioids market re…
- 局所的痛み軽減の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Topical Pain Relief market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.0% in the forecast period of 2020 to 2025 and will expected to reach USD 8328.9 million by 2025, from USD 7115.4 million in 2019. The Topical Pain Rel…
- 非オピオイド疼痛パッチの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Non-opioid Pain Patch market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.5% in the forecast period of 2020 to 2025 and will expected to reach USD 718.9 million by 2025, from USD 651.4 million in 2019. The Non-opioid Pain …
- 干渉抑制コンデンサの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Interference Suppression Capacitors market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Interfere…